2020 ISAR Global Research Project
Describe the Clinical Outcome Before and After Biologic Treatment by Biologic Class, by Individual Biologic, and by Subgroups of Baseline Characteristics (LUMINANT)
- To describe the proportions of patients by biologic class and drug.
- To describe clinical outcomes before and after biologic initiation.
- To describe clinical outcomes before and after biologic initiation for demographic/clinical subgroups (e.g. early/late age of onset, nasal polyps).
- Prof. George C. Christoff (Bulgaria)
- Prof. Todor A. Popov (Bulgaria)